Safety considerations when managing gastro-esophageal reflux disease in infants

References

• Curien-Chotard M, Jantchou P. Natural history of gastroesophageal reflux in infancy: new data from a prospective cohort. BMC Pediatr. 2020 April 7;20(1):152.
   PubMed Web of Science ®Google Scholar
• Hegar B, Boediarso A, Firmansyah A, et al. Investigation of regurgitation and other symptoms of gastroesophageal reflux in Indonesian infants. World J Gastroenterol. 2004;10(12):1795–1797. .
   PubMed Web of Science ®Google Scholar
• Orenstein SR, Shalaby TM, Cohn JF. Reflux symptoms in 100 normal infants: diagnostic validity of the infant gastroesophageal reflux questionnaire. Clin Pediatr (Phila). 1996 December;35(12):607–614.
   PubMed Web of Science ®Google Scholar
• Nelson SP, Chen EH, Syniar GM, et al. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric practice research group. Arch Pediatr Adolesc Med. 1997 June;151(6):569–572.
   PubMedGoogle Scholar
• Hegar B, Dewanti NR, Kadim M, et al. Natural evolution of regurgitation in healthy infants. Acta Paediatr. 2009 July;98(7):1189–1193.
   PubMed Web of Science ®Google Scholar
• Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics. 2002 June;109(6):1061–1067.
   PubMed Web of Science ®Google Scholar
• Nelson SP, Chen EH, Syniar GM, et al. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med. 2000 February;154(2):150–154.
   PubMedGoogle Scholar
• Benninga MA, Faure C, Hyman PE, et al. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2016 February 15;150:1443–1455.e2.
   Web of Science ®Google Scholar
• Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American society for pediatric gastroenterology, hepatology, and nutrition and the european society for pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2018 March;66(3):516–554.
   PubMed Web of Science ®Google Scholar
• Euler AR. Use of bethanechol for the treatment of gastroesophageal reflux. J Pediatr. 1980;96(2):321–324.
   PubMed Web of Science ®Google Scholar
• Salvatore S, Pagliarin F, Huysentruyt K, et al. Distress in infants and young children: don't blame acid reflux. J Pediatr Gastroenterol Nutr 220 Oct;71(4):465–469.
   Google Scholar
• Ng. N 2018 surveillance of gastro-oesophageal reflux disease in children and young people: diagnosis and management. Oct 2019
   Google Scholar
• Orenstein SR, Whitington PF, Orenstein DM. The infant seat as treatment for gastroesophageal reflux. N Engl J Med. 1983 September 29;309(13):760–763.
   PubMed Web of Science ®Google Scholar
• Meyers WF, Herbst JJ. Effectiveness of positioning therapy for gastroesophageal reflux. Pediatrics. 1982 June;69(6):768–772.
   PubMed Web of Science ®Google Scholar
• Quitadamo P, Tambucci R, Alessandrella A, et al. Association between body positioning and gastroesophageal reflux in paediatric age. Acta Paediatr. 2020 May;109(5):1033–1039.
   Google Scholar
• Jung WJ, Yang HJ, Min TK, et al. The efficacy of the upright position on gastro-esophageal reflux and reflux-related respiratory symptoms in infants with chronic respiratory symptoms. Allergy Asthma Immunol Res. 2012 January;4(1):17–23.
   PubMed Web of Science ®Google Scholar
• Vandenplas Y, De Wolf D, Deneyer M, et al. Incidence of gastroesophageal reflux in sleep, awake, fasted, and postcibal periods in asymptomatic and symptomatic infants. J Pediatr Gastroenterol Nutr. 1988 March-April;7(2):177–180.
   PubMed Web of Science ®Google Scholar
• Vandenplas Y, Sacre-Smits L. Seventeen-hour continuous esophageal pH monitoring in the newborn: evaluation of the influence of position in asymptomatic and symptomatic babies. J Pediatr Gastroenterol Nutr. 1985 June;4(3):356–361.
   PubMed Web of Science ®Google Scholar
• Ramenofsky ML, Leape LL. Continuous upper esophageal pH monitoring in infants and children with gastroesophageal reflux, pneumonia, and apneic spells. J Pediatr Surg. 1981 June;16(3):374–378.
   PubMed Web of Science ®Google Scholar
• Fleming PJ, Blair PS, Bacon C, et al. Environment of infants during sleep and risk of the sudden infant death syndrome: results of 1993-5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Confidential enquiry into stillbirths and deaths regional coordinators and researchers. BMJ. 1996 July 27;313(7051):191–195.
   PubMedGoogle Scholar
• Loots C, Kritas S, van Wijk M, et al. Body positioning and medical therapy for infantile gastroesophageal reflux symptoms. J Pediatr Gastroenterol Nutr. 2014 August;59(2):237–243.
   PubMed Web of Science ®Google Scholar
• Tobin JM, McCloud P, Cameron DJ. Posture and gastro-oesophageal reflux: a case for left lateral positioning. Arch Dis Child. 1997 March;76(3):254–258.
   PubMed Web of Science ®Google Scholar
• Omari TI, Rommel N, Staunton E, et al. Paradoxical impact of body positioning on gastroesophageal reflux and gastric emptying in the premature neonate. J Pediatr. 2004 August;145(2):194–200.
   PubMed Web of Science ®Google Scholar
• van Wijk MP, Benninga MA, Dent J, et al. Effect of body position changes on postprandial gastroesophageal reflux and gastric emptying in the healthy premature neonate. J Pediatr. 2007 Dec;151(6):585–590. 590 e1–2.
   PubMed Web of Science ®Google Scholar
• Corvaglia L, Rotatori R, Ferlini M, et al. The effect of body positioning on gastroesophageal reflux in premature infants: evaluation by combined impedance and pH monitoring. J Pediatr. 2007 Dec;151(6):591–596. 596 e1.
   PubMed Web of Science ®Google Scholar
• Bagucka B, De Schepper J, Peelman M, et al. Acid gastro-esophageal reflux in the 10 degrees-reversed-Trendelenburg-position in supine sleeping infants. Acta Paediatr Taiwan. 1999 September-October;40(5):298–301.
   PubMedGoogle Scholar
• Moon RY. Task force on sudden infant death S. SIDS and other sleep-related infant deaths: updated 2016 recommendations for a safe infant sleeping environment. Pediatrics. 2016 Nov;138(5):e20162940.
   Web of Science ®Google Scholar
• Vandenplas Y, De Schepper J, Verheyden S, et al. A preliminary report on the efficacy of the multicare AR-bed in 3-week-3-month-old infants on regurgitation, associated symptoms and acid reflux. Arch Dis Child. 2010 January;95(1):26–30.
   PubMed Web of Science ®Google Scholar
• Li DK, Petitti DB, Willinger M, et al. Infant sleeping position and the risk of sudden infant death syndrome in California, 1997-2000. Am J Epidemiol. 2003 Mar 1;157(5):446–455.
   PubMed Web of Science ®Google Scholar
• Malloy MH. Trends in postneonatal aspiration deaths and reclassification of sudden infant death syndrome: impact of the “Back to Sleep” program. Pediatrics. 2002 April;109(4):661–665.
   PubMed Web of Science ®Google Scholar
• Omari TI, Barnett CP, Benninga MA, et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut. 2002 October;51(4):475–479.
   PubMed Web of Science ®Google Scholar
• Khoshoo V, Ross G, Brown S, et al. Smaller volume, thickened formulas in the management of gastroesophageal reflux in thriving infants. J Pediatr Gastroenterol Nutr. 2000;31(5):554–556.
   PubMed Web of Science ®Google Scholar
• Davies I, Burman-Roy S, Murphy MS. Gastro-oesophageal reflux disease in children: NICE guidance. Bmj. 2015 January 14;350:g7703.
   PubMedGoogle Scholar
• Ostrom KM, Jacobs JR, Merritt RJ, et al. Decreased regurgitation with a soy formula containing added soy fiber. Clin Pediatr (Phila). 2006 January-February;45(1):29–36.
   PubMed Web of Science ®Google Scholar
• Chao HC, Vandenplas Y. Effect of cereal-thickened formula and upright positioning on regurgitation, gastric emptying, and weight gain in infants with regurgitation. Nutrition. 2007 January;23(1):23–28.
   PubMed Web of Science ®Google Scholar
• Vanderhoof JA, Moran JR, Harris CL, et al. Efficacy of a pre-thickened infant formula: a multicenter, double-blind, randomized, placebo-controlled parallel group trial in 104 infants with symptomatic gastroesophageal reflux. Clin Pediatr (Phila). 2003 July-August;42(6):483–495.
   PubMed Web of Science ®Google Scholar
• Iacono G, Vetrano S, Cataldo F, et al. Clinical trial with thickened feeding for treatment of regurgitation in infants. Dig Liver Dis. 2002 July;34(7):532–533.
   PubMedGoogle Scholar
• Vandenplas Y, Hachimi-Idrissi S, Casteels A, et al. A clinical trial with an “anti-regurgitation” formula. Eur J Pediatr. 1994 Jun;153(6):419–423.
   PubMed Web of Science ®Google Scholar
• Miyazawa R, Tomomasa T, Kaneko H, et al. Effect of formula thickened with locust bean gum on gastric emptying in infants. J Paediatr Child Health. 2006 December;42(12):808–812. .
   PubMed Web of Science ®Google Scholar
• Miyazawa R, Tomomasa T, Kaneko H, et al. Effect of locust bean gum in anti-regurgitant milk on the regurgitation in uncomplicated gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2004 May;38(5):479–483.
   PubMed Web of Science ®Google Scholar
• Miyazawa R, Tomomasa T, Kaneko H, et al. Effect of formula thickened with reduced concentration of locust bean gum on gastroesophageal reflux. Acta Paediatr. 2007 June;96(6):910–914.
   PubMed Web of Science ®Google Scholar
• Wenzl TG, Schneider S, Scheele F, et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Pediatrics. 2003 April;111(4 Pt 1):e355–9.
   PubMed Web of Science ®Google Scholar
• Moukarzel AA, Abdelnour H, Akatcherian C. Effects of a prethickened formula on esophageal pH and gastric emptying of infants with GER. J Clin Gastroenterol. 2007 October;41(9):823–829.
   PubMed Web of Science ®Google Scholar
• Xinias I, Mouane N, Le Luyer B, et al. Cornstarch thickened formula reduces oesophageal acid exposure time in infants. Dig Liver Dis. 2005 January;37(1):23–27.
   PubMedGoogle Scholar
• Chao HC, Vandenplas Y. Comparison of the effect of a cornstarch thickened formula and strengthened regular formula on regurgitation, gastric emptying and weight gain in infantile regurgitation. Dis Esophagus. 2007;20(2):155–160.
   PubMed Web of Science ®Google Scholar
• Georgieva M, Manios Y, Rasheva N, et al. Effects of carob-bean gum thickened formulas on infants’ reflux and tolerance indices. World J Clin Pediatr. 2016 Feb 8;5(1):118–127.
   PubMedGoogle Scholar
• Salvatore S, Savino F, Singendonk M, et al. Thickened infant formula: what to know. Nutrition. 2018 May;49:51–56.
   PubMed Web of Science ®Google Scholar
• Duncan DR, Larson K, Rosen RL. Clinical aspects of thickeners for pediatric gastroesophageal reflux and propharyngeal dysphagia. Curr Gastroenterol Rep. 2019 May 16;21(7):30.
   PubMedGoogle Scholar
• Kwok TC, Ojha S, Dorling J. Feed thickener for infants up to six months of age with gastro-oesophageal reflux. Cochrane Database Syst Rev. 2017 December 5;12(12):Cd003211.
   PubMedGoogle Scholar
• Horvath A, Dziechciarz P, Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics. 2008 December;122(6):e1268–77.
   PubMed Web of Science ®Google Scholar
• Pina D, Villoslada F, Gines G, et al. Thickened infant formula, rheological study of the “in vitro” properties. Anales De Pediatría (Barcelona, Spain:. 2003 2010 May 01;72:302–308.
   Google Scholar
• Gonzalez Bermudez C, Frontela C, López-Nicolás R, et al. Effect of adding different thickening agents on the viscosity properties and in vitro mineral availability of infant formula. Food Chem. 2014 September 01;159:5–11.
   PubMed Web of Science ®Google Scholar
• Penna FJ, Norton RC, Carvalho AS, et al. Comparison between pre-thickened and home-thickened formulas in gastroesophageal reflux treatement. J Pediatr (Rio J). 2003 January-February;79(1):49–54.
   PubMedGoogle Scholar
• Vandenplas Y, Gutierrez-Castrellon P, Velasco-Benitez C, et al. Practical algorithms for managing common gastrointestinal symptoms in infants. Nutrition. 2013 [2013 January 01];29(1):184–194.
   PubMed Web of Science ®Google Scholar
• Koletzko B, Baker S, Cleghorn G, et al. Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr. 2005;41(5):584–599.
   PubMed Web of Science ®Google Scholar
• Davidson G. The role of lower esophageal sphincter function and dysmotility in gastroesophageal reflux in premature infants and in the first year of life. J Pediatr Gastroenterol Nutr. 2003 November-December;37(Suppl 1):S17–22.
   PubMedGoogle Scholar
• Pearson F, Johnson MJ, Leaf AA. Milk osmolality: does it matter? Arch Dis Child Fetal Neonatal Ed. 2013 March;98(2):F166–9.
   PubMed Web of Science ®Google Scholar
• XC Farzan SFK, Margaret R, Chen Y. FDA concludes study of arsenic in rice products; no dietary changes recommended. AAP News.
   Google Scholar
• Meyer R, Carey MP, Turner PJ, et al. Low inorganic arsenic in hydrolysed rice formula used for cow’s milk protein allergy. Pediatr Allergy Immunol. 2018 August;29(5):561–563.
   PubMed Web of Science ®Google Scholar
• Beal J, Silverman B, Bellant J, et al. Late onset necrotizing enterocolitis in infants following use of a xanthan gum-containing thickening agent. J Pediatr. 2012 August;161(2):354–356. .
   PubMed Web of Science ®Google Scholar
• Clarke P, Robinson MJ. Thickening milk feeds may cause necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2004 May;89(3):F280.
   PubMed Web of Science ®Google Scholar
• González-Bermúdez CA, López-Nicolás R, Peso-Echarri P, et al. Effects of different thickening agents on infant gut microbiota. Food Funct. 2018 March 1;9(3):1768–1778.
   PubMed Web of Science ®Google Scholar
• Gamage H, Tetu SG, Chong RWW, et al. Cereal products derived from wheat, sorghum, rice and oats alter the infant gut microbiota in vitro. Sci Rep. 2017 October 30;7(1):14312.
   PubMedGoogle Scholar
• Sharpe K, Ward L, Cichero J, et al. Thickened fluids and water absorption in rats and humans. Dysphagia. 2007 July;22(3):193–203.
   PubMed Web of Science ®Google Scholar
• Mascarenhas R, Landry L, Khoshoo V. Difficulty in defecation in infants with gastroesophageal reflux treated with smaller volume feeds thickened with rice cereal. Clin Pediatr (Phila). 2005 October;44(8):671–673.
   PubMed Web of Science ®Google Scholar
• Bosscher D, Van Caillie-Bertrand M, Van Cauwenbergh R, et al. Availabilities of calcium, iron, and zinc from dairy infant formulas is affected by soluble dietary fibers and modified starch fractions. Nutrition. 2003 July-August;19(7–8):641–645.
   PubMed Web of Science ®Google Scholar
• Aggett PJ, Agostoni C, Goulet O, et al. Antireflux or antiregurgitation milk products for infants and young children: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2002 May;34(5):496–498.
   PubMed Web of Science ®Google Scholar
• Food. ECSCf. Opinion on certain additives to foods for infants and young children in good health and in foods for special medical purposes for infants and young children: locust bean gum. 1997. Document XXIV/1270/97, Annex II.
   Google Scholar
• Savino F, Muratore MC, Silvestro L, et al. Allergy to carob gum in an infant. J Pediatr Gastroenterol Nutr. 1999 October;29(4):475–476.
   PubMed Web of Science ®Google Scholar
• Orenstein SR, Shalaby TM, Putnam PE. Thickened feedings as a cause of increased coughing when used as therapy for gastroesophageal reflux in infants.J Pediatr. 1992 [1992 December 01];121(6):913–915.
   PubMed Web of Science ®Google Scholar
• Tounian P, Speijers G, Oozer R, et al. Patrick Tounian LM, Speijers G, Oozeer R, et al. Effectiveness and tolerance of a locust bean gum thickened formula: a real-life study. Pediatr Gastroenterol Hepatol Nutr. 2020 (In press).
   Google Scholar
• Ummarino D, Miele E, Martinelli M, et al. Effect of magnesium alginate plus simethicone on gastroesophageal reflux in infants. J Pediatr Gastroenterol Nutr. 2015 Feb;60(2):230–235.
   PubMed Web of Science ®Google Scholar
• Vandenplas Y, Koletzko S, Isolauri E, et al. Guidelines for the diagnosis and management of cow’s milk protein allergy in infants. Arch Dis Child. 2007 October;92(10):902–908.
   PubMed Web of Science ®Google Scholar
• Koletzko S, Niggemann B, Arato A, et al. Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI committee practical guidelines. J Pediatr Gastroenterol Nutr. 2012 August;55(2):221–229.
   PubMed Web of Science ®Google Scholar
• Borrelli O, Mancini V, Thapar N, et al. Cow’s milk challenge increases weakly acidic reflux in children with cow’s milk allergy and gastroesophageal reflux disease. J Pediatr. 2012 September;161(3):476–481. e1.
   PubMed Web of Science ®Google Scholar
• Corvaglia L, Mariani E, Aceti A, et al. Extensively hydrolyzed protein formula reduces acid gastro-esophageal reflux in symptomatic preterm infants. Early Hum Dev. 2013 July;89(7):453–455.
   PubMed Web of Science ®Google Scholar
• Vandenplas Y, De Greef E, group As. Extensive protein hydrolysate formula effectively reduces regurgitation in infants with positive and negative challenge tests for cow’s milk allergy. Acta Paediatrica. 2014;103(6):e243–e250.
   PubMed Web of Science ®Google Scholar
• Shergill-Bonner R. Infantile colic: practicalities of management, including dietary aspects. J Fam Health Care.2010;20(6):206–209.
   PubMedGoogle Scholar
• Garzi A, Messina M, Frati F, et al. An extensively hydrolysed cow’s milk formula improves clinical symptoms of gastroesophageal reflux and reduces the gastric emptying time in infants. Allergol Immunopathol (Madr). 2002 Jan-Feb;30(1):36–41.
   PubMedGoogle Scholar
• Vandenplas Y, Gottrand F, Veereman-Wauters G, et al. Gastrointestinal manifestations of cow’s milk protein allergy and gastrointestinal motility. Acta Paediatr. 2012 Nov;101(11):1105–1109.
   PubMed Web of Science ®Google Scholar
• Indrio F, Di Mauro A, Riezzo G, et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr. 2014 March;168(3):228–233.
   PubMed Web of Science ®Google Scholar
• Garofoli F, Civardi E, Indrio F, et al. The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in full-term breastfed infants. Int J Food Sci Nutr. 2014 August;65(5):646–648.
   PubMed Web of Science ®Google Scholar
• Indrio F, Riezzo G, Raimondi F, et al. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Invest. 2011 Apr;41(4):417–422.
   PubMed Web of Science ®Google Scholar
• Ong TG, Gordon M, Banks SS, et al. Probiotics to prevent infantile colic. Cochrane Database Syst Rev. 2019 March 13;3(3):Cd012473.
   PubMedGoogle Scholar
• Neu M, Pan Z, Workman R, et al. Benefits of massage therapy for infants with symptoms of gastroesophageal reflux disease. Biol Res Nurs. 2014 Oct;16(4):387–397.
   PubMed Web of Science ®Google Scholar
• Mangat AK, Oei JL, Chen K, et al. A review of non-pharmacological treatments for pain management in newborn infants. Children (Basel). 2018 Sep 20;5(10):130.
   PubMed Web of Science ®Google Scholar
• Arikan D, Alp H, Gozum S, et al. Effectiveness of massage, sucrose solution, herbal tea or hydrolysed formula in the treatment of infantile colic. J Clin Nurs. 2008 July;17(13):1754–1761.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Castrellon P, Indrio F, Bolio-Galvis A, et al. Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: systematic review with network meta-analysis. Medicine (Baltimore). 2017 December;96(51):e9375.
   PubMed Web of Science ®Google Scholar
• Ellwood J, Draper-Rodi J, Carnes D. Comparison of common interventions for the treatment of infantile colic: a systematic review of reviews and guidelines. BMJ Open. 2020 February 25;10(2):e035405.
   PubMed Web of Science ®Google Scholar
• Otake K, Uchida K, Mori K, et al. Efficacy of the Japanese herbal medicine rikkunshito in infants with gastroesophageal reflux disease. Pediatr Int. 2015 August;57(4):673–676.
   PubMed Web of Science ®Google Scholar
• Yeh AM, Golianu B. Integrative treatment of reflux and functional dyspepsia in children. Children (Basel). 2014 August 18;1(2):119–133.
   PubMedGoogle Scholar
• Pandolfino JE, Kahrilas PJ. Smoking and gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol. 2000 August;12(8):837–842.
   PubMed Web of Science ®Google Scholar
• Alaswad B, Toubas PL, Grunow JE. Environmental tobacco smoke exposure and gastroesophageal reflux in infants with apparent life-threatening events. J Okla State Med Assoc 1996 July;89(7):233–237.
   PubMedGoogle Scholar
• Djeddi D, Stephan-Blanchard E, Leke A, et al. Effects of smoking exposure in enfants on gastroesophageal reflux as a function of the sleep-wakefulness state. J Pediatr. 2018 Oct;201:147–153.
   PubMed Web of Science ®Google Scholar
• Koebnick C, Getahun D, Smith N, et al. Extreme childhood obesity is associated with increased risk for gastroesophageal reflux disease in a large population-based study. Int J Pediatr Obes. 2011 Jun;6(2–2):e257–63.
   PubMed Web of Science ®Google Scholar
• Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006 May 8;166(9):965–971.
   PubMedGoogle Scholar
• Tsou VM, Young RM, Hart MH, et al. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics. 1991 Feb;87(2):148–151.
   PubMed Web of Science ®Google Scholar
• Woodard-Knight L, Fudge A, Teubner J, et al. Aluminium absorption and antacid therapy in infancy. J Paediatr Child Health. 1992 [1992/June//];28(3):257–259. .
   PubMed Web of Science ®Google Scholar
• Bor S, Kalkan İH, Çelebi A, et al. Alginates: from the ocean to gastroesophageal reflux disease treatment. Turk J Gastroenterol. 2019;30(Suppl2):109–136.
   PubMedGoogle Scholar
• Dettmar PW, Gil-Gonzalez D, Fisher J, et al. A comparative study on the raft chemical properties of various alginate antacid raft-forming products. Drug Dev Ind Pharm. 2018 Jan;44(1):30–39.
   PubMed Web of Science ®Google Scholar
• Mandel, Daggy, Brodie, et al. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther. 2000;14(6):669–690.
   PubMed Web of Science ®Google Scholar
• Johnson FA, Craig DQM, Mercer A, et al. The use of image analysis as a means of monitoring bubble formation in alginate rafts. Int J Pharm. 1998 [1998 August 15];170(2):179–185.
   Google Scholar
• Tighe M, Afzal NA, Bevan A, et al. Pharmacological treatment of children with gastro‐oesophageal reflux. Cochrane Database Syst Rev. 2014(11). doi:10.1002/14651858.CD008550.pub2.
   PubMed Web of Science ®Google Scholar
• Miller S. Comparison of the efficacy and safety of a new aluminium-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux. Curr Med Res Opin. 1999;15(3):160–168.
   PubMed Web of Science ®Google Scholar
• Salvatore S, Ripepi A, Huysentruyt K, et al. The effect of alginate in gastroesophageal reflux in infants. Paediatr Drugs. 2018 December;20(6):575–583.
   PubMed Web of Science ®Google Scholar
• Del Buono R, Wenzl TG, Ball G, et al. Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH. Arch Dis Child. 2005;90(5):460–463.
   PubMed Web of Science ®Google Scholar
• Baldassarre ME, Di Mauro A, Pignatelli MC, et al. Magnesium alginate in gastro-esophageal reflux: A randomized multicenter cross-over study in infants. Int J Environ Res Public Health. 2019 December 20;17:1.
   Web of Science ®Google Scholar
• Keady S. Update on drugs for gastrooesophageal reflux disease. Arch Dis Child Educ Pract Ed. 2007;09/01(92):ep114–8.
   Google Scholar
• BNF for children. British medical association rpsogb, royal college of paediatrics and child health, neonatal and paediatric pharmacists group. BNF for children. London: BMJ Group, Pharmaceutical Press, RCPCH; 2013. p. 2013.
   Google Scholar
• Sorbie AL, Symon DN, Stockdale EJ. Gaviscon bezoars. Arch Dis Child. 1984 September;59(9):905–906.
   PubMed Web of Science ®Google Scholar
• NICE. Gastro-oesophageal reflux disease in children and young people: diagnosis and management. 2015.
   Google Scholar
• El-Mahdy MA, Mansoor FA, Jadcherla SR. Pharmacological management of gastroesophageal reflux disease in infants: current opinions. Curr Opin Pharmacol. 2017 December;37:112–117.
   PubMed Web of Science ®Google Scholar
• Corsonello A, Lattanzio F, Bustacchini S, et al. Adverse events of proton pump inhibitors: potential mechanisms. Curr Drug Metab. 2018;19(2):142–154.
   PubMed Web of Science ®Google Scholar
• Cucchiara S, Staiano A, Romaniello G, et al. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis. Arch Dis Child. 1984 September;59(9):842–847.
   PubMed Web of Science ®Google Scholar
• Simeone D, Caria MC, Miele E, et al. Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine. J Pediatr Gastroenterol Nutr. 1997 July;25(1):51–55.
   PubMed Web of Science ®Google Scholar
• Ummarino D, Miele E, Masi P, et al. Impact of antisecretory treatment on respiratory symptoms of gastroesophageal reflux disease in children. Dis Esophagus. 2012 November-December;25(8):671–677.
   PubMed Web of Science ®Google Scholar
• Cucchiara S, Minella R, Iervolino C, et al. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. Arch Dis Child. 1993 December;69(6):655–659.
   PubMed Web of Science ®Google Scholar
• Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006 May;117(5):e817–20.
   PubMed Web of Science ®Google Scholar
• Herrmann R, Shaw RG, Fone DJ. Ranitidine-associated recurrent acute pancreatitis. Aust N Z J Med. 1990 June;20(3):243–244.
   PubMedGoogle Scholar
• Anderson BJ, Lerman J, Coté CJ. 7 - Pharmacokinetics and pharmacology of drugs used in children. In: Coté CJ, Lerman J, Anderson BJ, editors. A practice of anesthesia for infants and children (Sixth Edition). Philadelphia: Content Repository Only!; 2019. p. 100–176.e45.
   Google Scholar
• Levy EI, Hoang DM, Vandenplas Y. The effects of proton pump inhibitors on the microbiome in young children. Acta Paediatrica. 2020 Aug;109(8):1531–1538.
   Web of Science ®Google Scholar
• Castellani C, Singer G, Kashofer K, et al. The influence of proton pump inhibitors on the fecal microbiome of infants with gastroesophageal reflux-a prospective longitudinal interventional study. Front Cell Infect Microbiol. 2017;7:444.
   PubMed Web of Science ®Google Scholar
• Freedberg DE, Lamousé-Smith ES, Lightdale JR, et al. Use of acid suppression medication is associated with risk for c. difficile infection in infants and children: a population-based study. Clin Infect Dis. 2015 September 15;61(6):912–917.
   PubMed Web of Science ®Google Scholar
• Belei O, Olariu L, Dobrescu A, et al. Is It useful to administer probiotics together with proton pump inhibitors in children with gastroesophageal reflux? J Neurogastroenterol Motil. 2018 January 30;24(1):51–57.
   PubMed Web of Science ®Google Scholar
• Hegar B, Hutapea EI, Advani N, et al. A double-blind placebo-controlled randomized trial on probiotics in small bowel bacterial overgrowth in children treated with omeprazole. J Pediatr (Rio J). 2013 July-August;89(4):381–387.
   PubMed Web of Science ®Google Scholar
• Sieczkowska A, Landowski P, Zagozdzon P, et al. Small bowel bacterial overgrowth asociated with Pprsistence of abdominal symptoms in children treated with a proton pump inhibitor. J Pediatr. 2015 May;166(5):1310–1312. e1.
   PubMed Web of Science ®Google Scholar
• Cares K, Al-Ansari N, Macha S, et al. Short article: risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children. Eur J Gastroenterol Hepatol. 2017 April;29(4):396–399.
   PubMed Web of Science ®Google Scholar
• De Bruyne P, Ito S. Toxicity of long-term use of proton pump inhibitors in children. Arch Dis Child. 2018 January;103(1):78–82.
   PubMed Web of Science ®Google Scholar
• Hassing R-J, Verbon A, de Visser H, et al. Proton pump inhibitors and gastroenteritis. Eur J Epidemiol. 2016 [2016 October 01];31(10):1057–1063.
   PubMed Web of Science ®Google Scholar
• Schutze GE, Willoughby RE. Committee on Infectious D. Clostridium difficile infection in infants and children. Pediatrics. 2013 January;131(1):196–200.
   PubMed Web of Science ®Google Scholar
• Blank ML, Parkin L, Zeng J, et al. Proton pump inhibitors and infant pneumonia/other lower respiratory tract infections: national nested case-control study. J Pediatr Gastroenterol Nutr. 2018 September;67(3):335–340.
   PubMed Web of Science ®Google Scholar
• Orenstein SR, Hassall E, Furmaga-Jablonska W, et al. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009 April;154(4):514–520. e4.
   PubMed Web of Science ®Google Scholar
• Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017 January;15(1):55–63.
   PubMed Web of Science ®Google Scholar
• Marsland BJ, Trompette A, Gollwitzer ES. The gut-lung axis in respiratory disease. Ann Am Thorac Soc. 2015 Nov;12(Suppl 2):S150–6.
   PubMed Web of Science ®Google Scholar
• Robinson LB, Camargo CA Jr. Acid suppressant medications and the risk of allergic diseases. Expert Rev Clin Immunol. 2018 September;14(9):771–780.
   PubMed Web of Science ®Google Scholar
• Malchodi L, Wagner K, Susi A, et al. Early acid suppression therapy exposure and fracture in young children. Pediatrics. 2019 July;144(1):e20182625.
   PubMed Web of Science ®Google Scholar
• Stark CM, Susi A, Emerick J, et al. Antibiotic and acid-suppression medications during early childhood are associated with obesity. Gut. 2019 January;68(1):62–69.
   PubMed Web of Science ®Google Scholar
• Oshima T, Miwa H. Potent potassium-competitive acid blockers: A new era for the treatment of acid-related diseases. J Neurogastroenterol Motil. 2018;24(3):334–344.
   PubMed Web of Science ®Google Scholar
• Scarpignato C, Hongo M, Wu JCY, et al. Pharmacologic treatment of GERD: where we are now, and where are we going? Ann N Y Acad Sci. 2020September;15.
   Google Scholar
• Bardou M, Fortinsky KJ, Chapelle N, et al. An update on the latest chemical therapies for reflux esophagitis in children. Expert Opin Pharmacother. 2019 February;20(2):231–239.
   PubMed Web of Science ®Google Scholar
• Omari TI, Benninga MA, Sansom L, et al. Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial. J Pediatr. 2006 October;149(4):468–474.
   PubMed Web of Science ®Google Scholar
• Vadlamudi NB, Hitch MC, Dimmitt RA, et al. Baclofen for the treatment of pediatric GERD. J Pediatr Gastroenterol Nutr. 2013 December;57(6):808–812.
   PubMed Web of Science ®Google Scholar
• Lau Moon Lin M, Robinson PD, Flank J, et al. The Safety of metoclopramide in children: A systematic review and meta-analysis. Drug Saf. 2016 July;39(7):675–687.
   PubMed Web of Science ®Google Scholar
• Lang L. FDA calls for boxed warning for metoclopramide. Gastroenterology. 2009;136(7):2039.
   Web of Science ®Google Scholar
• Johannes CB, Varas-Lorenzo C, McQuay LJ, et al. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. Pharmacoepidemiology and Drug Safety. 2010 September;19(9):881–888.
   PubMed Web of Science ®Google Scholar
• van Noord C, Dieleman JP, van Herpen G, et al. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf. 2010 November 1;33(11):1003–1014.
   PubMed Web of Science ®Google Scholar
• Rocha CM, Barbosa MM. QT interval prolongation associated with the oral use of domperidone in an infant. Pediatr Cardiol. 2005 September-October;26(5):720–723.
   PubMed Web of Science ®Google Scholar
• Djeddi D, Kongolo G, Lefaix C, et al. Effect of domperidone on QT interval in neonates. J Pediatr. 2008 November;153(5):663–666.
   PubMed Web of Science ®Google Scholar
• Gunlemez A, Babaoglu A, Arisoy AE, et al. Effect of domperidone on the QTc interval in premature infants. J Perinatol. 2010 January;30(1):50–53.
   PubMed Web of Science ®Google Scholar
• Vieira MC, Miyague NI, Van Steen K, et al. Effects of domperidone on QTc interval in infants. Acta Paediatr. 2012 May;101(5):494–496.
   PubMed Web of Science ®Google Scholar
• Ngoenmak T, Treepongkaruna S, Buddharaksa Y, et al. Effects of domperidone on QT interval in children with gastroesophageal reflux disease. Pediatr Neonatol. 2016 February;57(1):60–64.
   PubMed Web of Science ®Google Scholar
• Dhakal OP, Dhakal M, Bhandari D. Domperidone-induced dystonia: a rare and troublesome complication. BMJ Case Rep. 2014 Jun 27; 2014:bcr2013200282.
   Google Scholar
• Shahbaz A, Elahi K, Affan M, et al. Acute dystonia secondary to domperidone in a pediatric patient. Cureus. 2018 November 13;10(11):e3587.
   PubMed Web of Science ®Google Scholar
• FAHMP. Flash VIG-news: domperidone: no longer approved for use in children due to a lack of efficacy.
   Google Scholar
• Dubin A, Kikkert M, Mirmiran M, et al. Cisapride associated with QTc prolongation in very low birth weight preterm infants. Pediatrics. 2001 June;107(6):1313–1316.
   PubMed Web of Science ®Google Scholar
• EMA. Opinion following an article 31 referral: cisapride. 2002.
   Google Scholar
• Maclennan S, Augood C, Cash-Gibson L, et al. Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev. 2010 April;14(4):CD002300.
   Google Scholar
• Wysowski DK, Corken A, Gallo-Torres H, et al. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions. Am J Gastroenterol. 2001 June;96(6):1698–1703.
   PubMed Web of Science ®Google Scholar
• E Jp D, Depoortere I, Tack J. The migrating motor complex: control mechanisms and its role in health and disease. Nat Rev Gastroenterol Hepatol. 2012;9:271–285.
   PubMed Web of Science ®Google Scholar
• Ballengee CR, Davalian F, Conaway MR, et al. Erythromycin and reflux events in premature neonates: A randomized clinical trial. J Pediatr Gastroenterol Nutr. 2018 December;67(6):720–725.
   PubMed Web of Science ®Google Scholar
• Mahon BE, Rosenman MB, Kleiman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr. 2001 September;139(3):380–384.
   PubMed Web of Science ®Google Scholar
• Ericson JE, Arnold C, Cheeseman J, et al. Use and safety of erythromycin and metoclopramide in hospitalized infants. J Pediatr Gastroenterol Nutr. 2015 September;61(3):334–339.
   PubMed Web of Science ®Google Scholar
• Gouyon JB, Benoit A, Betremieux P, et al. Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants. Pediatr Infect Dis J. 1994 September;13(9):840–841.
   PubMed Web of Science ®Google Scholar
• Long SS. Optimizing antimicrobial therapy in children. J Infect. 2016 July;5(72 Suppl):S91–7.
   Google Scholar
• Lam HS, Ng PC. Use of prokinetics in the preterm infant. Curr Opin Pediatr. 2011 April;23(2):156–160.
   PubMed Web of Science ®Google Scholar
• Levi P, Marmo F, Saluzzo C, et al. Bethanechol versus antiacids in the treatment of gastroesophageal reflux. Helv Paediatr Acta. 1985 December;40(5):349–359.
   PubMedGoogle Scholar
• Shafrir Y, Levy Y, Beharab A, et al. Acute dystonic reaction to bethanechol–a direct acetylcholine receptor agonist. Dev Med Child Neurol. 1986 October;28(5):646–648.
   PubMed Web of Science ®Google Scholar
• Gaitonde S, Malik RD, Christie AL, et al. Bethanechol: is it still being prescribed for bladder dysfunction in women? Int J Clin Pract. 2019 August;73(8):e13248.
   PubMed Web of Science ®Google Scholar
• Rothenberg SS. Two decades of experience with laparoscopic nissen fundoplication in infants and children: a critical evaluation of indications, technique, and results. J Laparoendosc Adv Surg Tech A. 2013 September;23(9):791–794.
   PubMed Web of Science ®Google Scholar
• Mauritz FA, van Herwaarden-lindeboom MY, Stomp W, et al. The effects and efficacy of antireflux surgery in children with gastroesophageal reflux disease: a systematic review. J Gastrointest Surg. 2011 October;15(10):1872–1878. .
   PubMed Web of Science ®Google Scholar
• Martin K, Deshaies C, Emil S. Outcomes of pediatric laparoscopic fundoplication: a critical review of the literature. Can J Gastroenterol Hepatol. 2014 February;28(2):97–102.
   PubMedGoogle Scholar
• Hegar B, Satari DH, Sjarif DR, et al. Regurgitation and gastroesophageal reflux disease in six to nine months old indonesian infants. Pediatr Gastroenterol Hepatol Nutr. 2013 December;16(4):240–247.
   PubMedGoogle Scholar
• Orenstein SR, McGowan JD. Efficacy of conservative therapy as taught in the primary care setting for symptoms suggesting infant gastroesophageal reflux. J Pediatr. 2008 March;152(3):310–314.
   PubMed Web of Science ®Google Scholar
• Orenstein SR. Crying in infant GERD: acid or volume? Heartburn or dyspepsia? Curr Gastroenterol Rep. 2008 October;10(5):433–436.
   PubMedGoogle Scholar